Recent studies also showed combination therapy involving HDAC inhibitors with DNA methyltransferase-1 (DNMT1) inhibition is synergistically effective in inducing apoptosis, differentiation and/or cell growth arrest in many cancers including breast cancer [100]. This evidence concerns the gene DNMT1 and breast carcinoma.